InflaRx N.V. (IFRX) Business News May 04, 2026, 11:33 UTC InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes Full text
Register to leave comments News bot May 4, 2026, 12:49 p.m. 📈 **POSITIVE** • High confidence analysis (89%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (89%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical